Abstract
Brain metastases (BrM) occur in 30% to 50% of patients with malignant tumours and represent a relevant cause of morbidity and mortality. As documented by the extensive clinical use of magnetic resonance imaging with contrast enhancement, 25% to 35% of patients with BrM have a single localisation to the brain. Conventional therapeutic options for single BrM consist of either neurosurgery, or whole brain irradiation, or a combination of both. Treatment finality for the majority of the patients is palliation and life expectancy is in the order of a few months. In the last decade, the development of radiosurgery has represented an important advancement in the treatment of patients with BrM. This radiotherapeutic technique represents a possible non-invasive alternative to surgical exeresis for patients with lesions
| Original language | English |
|---|---|
| Pages (from-to) | 38-44 |
| Number of pages | 7 |
| Journal | FORUM - Trends in Experimental and Clinical Medicine |
| Volume | 11 |
| Issue number | 1 |
| Publication status | Published - 2001 |
Fingerprint
Keywords
- Neurosurgery
- Radiosurgery
- Single brain metastasis
- Whole brain radiotherapy
ASJC Scopus subject areas
- Medicine(all)
Cite this
Treatment of single brain metastases. / Gandola, L.; Navarria, P.; Lombardi, F.
In: FORUM - Trends in Experimental and Clinical Medicine, Vol. 11, No. 1, 2001, p. 38-44.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Treatment of single brain metastases
AU - Gandola, L.
AU - Navarria, P.
AU - Lombardi, F.
PY - 2001
Y1 - 2001
N2 - Brain metastases (BrM) occur in 30% to 50% of patients with malignant tumours and represent a relevant cause of morbidity and mortality. As documented by the extensive clinical use of magnetic resonance imaging with contrast enhancement, 25% to 35% of patients with BrM have a single localisation to the brain. Conventional therapeutic options for single BrM consist of either neurosurgery, or whole brain irradiation, or a combination of both. Treatment finality for the majority of the patients is palliation and life expectancy is in the order of a few months. In the last decade, the development of radiosurgery has represented an important advancement in the treatment of patients with BrM. This radiotherapeutic technique represents a possible non-invasive alternative to surgical exeresis for patients with lesions
AB - Brain metastases (BrM) occur in 30% to 50% of patients with malignant tumours and represent a relevant cause of morbidity and mortality. As documented by the extensive clinical use of magnetic resonance imaging with contrast enhancement, 25% to 35% of patients with BrM have a single localisation to the brain. Conventional therapeutic options for single BrM consist of either neurosurgery, or whole brain irradiation, or a combination of both. Treatment finality for the majority of the patients is palliation and life expectancy is in the order of a few months. In the last decade, the development of radiosurgery has represented an important advancement in the treatment of patients with BrM. This radiotherapeutic technique represents a possible non-invasive alternative to surgical exeresis for patients with lesions
KW - Neurosurgery
KW - Radiosurgery
KW - Single brain metastasis
KW - Whole brain radiotherapy
UR - http://www.scopus.com/inward/record.url?scp=0035197034&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035197034&partnerID=8YFLogxK
M3 - Article
C2 - 11734863
AN - SCOPUS:0035197034
VL - 11
SP - 38
EP - 44
JO - FORUM - Trends in Experimental and Clinical Medicine
JF - FORUM - Trends in Experimental and Clinical Medicine
SN - 1121-8142
IS - 1
ER -